Literature DB >> 6138169

Vasoactive intestinal peptide inhibitory innervation in bovine mesenteric lymphatics. A histochemical and pharmacological study.

T Ohhashi, J A Olschowka, D M Jacobowitz.   

Abstract

The localization of vasoactive intestinal peptide-immunoreactive nerves innervating bovine lymphatic vessels was studied by an immunohistochemical technique. Nerve fibers containing vasoactive intestinal peptide immunoreactivity were present in the smooth muscle layers as well as in the adventitia of all mesenteric lymphatics that were examined. The effect of vasoactive intestinal peptide on isolated lymphatic vessels in vitro was studied. Vasoactive intestinal peptide caused a concentration-dependent relaxation of bradykinin-induced contractions of lymphatic vessels. The threshold and maximum relaxations were achieved with vasoactive intestinal peptide at concentrations less than 6 X 10(-9) M and 3 X 10(-7) M, respectively. The relaxant response to vasoactive intestinal peptide was not modified by atropine, propranolol, bretylium, or tetrodotoxin. These results suggest that vasoactive intestinal peptide may be a possible inhibitory neurotransmitter that causes relaxation of lymphatic vessels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138169     DOI: 10.1161/01.res.53.4.535

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.

Authors:  Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz
Journal:  J Physiol       Date:  2012-03-25       Impact factor: 5.182

2.  Adaptation of mesenteric collecting lymphatic pump function following acute alcohol intoxication.

Authors:  Flavia M Souza-Smith; Kristine M Kurtz; Patricia E Molina; Jerome W Breslin
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

Review 3.  Lymphatic pumping: mechanics, mechanisms and malfunction.

Authors:  Joshua P Scallan; Scott D Zawieja; Jorge A Castorena-Gonzalez; Michael J Davis
Journal:  J Physiol       Date:  2016-08-02       Impact factor: 5.182

4.  Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.

Authors:  Sanjukta Chakraborty; Zhanna Nepiyushchikh; Michael J Davis; David C Zawieja; Mariappan Muthuchamy
Journal:  Microcirculation       Date:  2011-01       Impact factor: 2.628

Review 5.  Lymphatic system: a vital link between metabolic syndrome and inflammation.

Authors:  Sanjukta Chakraborty; Scott Zawieja; Wei Wang; David C Zawieja; Mariappan Muthuchamy
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 6.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

7.  Intraocular Pressure-Lowering Effect of Latanoprost Is Hampered by Defective Cervical Lymphatic Drainage.

Authors:  Young Kook Kim; Kyeong Ik Na; Jin Wook Jeoung; Ki Ho Park
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 8.  Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research.

Authors:  Eleonóra Spekker; Masaru Tanaka; Ágnes Szabó; László Vécsei
Journal:  Biomedicines       Date:  2021-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.